Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic biomarkers in epithelial ovarian cancer.

Cancer letters - 28 Jan 2014

Gloss Brian S, Samimi Goli

Abstract excerpt

Ovarian cancer is the most lethal gynecological malignancy and the 5th leading cause of cancer death in women. Women with ovarian cancer are typically diagnosed at late stage, when the cancer has spread into the peritoneal cavity and complete surgical removal is difficult. The 5-year survival time for patients diagnosed at this stage is 30%, in contrast to a 5-year survival of 90% for patients diagnosed at early...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial
Share to DNA Methylation
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasms, Glandular and Epithelial

Share to Ovarian Neoplasms

Share to Predictive Value of Tests

Source

Identifiers

PMID: 22245949
DOI: 10.1016/j.canlet.2011.12.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic biomarkers in epithelial ovarian cancer.PMID 22245949Read ↗

DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatmentSemantic proximity Read ↗

Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)Semantic proximity Read ↗

Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancerSemantic proximity Read ↗

Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibilitySemantic proximity Read ↗

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinomaSemantic proximity Read ↗

Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectivesSemantic proximity Read ↗

Epithelial Ovarian Cancer: Disease Etiology, Treatment, Detection, and Investigational Gene, Metabolite, and Protein BiomarkersSemantic proximity Read ↗

Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.Semantic proximity Read ↗

Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancerSemantic proximity Read ↗

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor LesionsSemantic proximity Read ↗

An overview of biomarkers for the ovarian cancer diagnosis.Semantic proximity Read ↗

Ovarian cancer biomarkers for molecular biosensors and translational medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.